LBF20207PG35: Difference between revisions
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
|LipidBank=XPR1743 | |LipidBank=XPR1743 | ||
|LipidMaps=LMFA03010061 | |LipidMaps=LMFA03010061 | ||
|SysName= 9- | |SysName= 9-Oxo-15S-hydroxy-prosta-5Z,13E-dien-1-oic acid | ||
|Common Name=&&11-deoxy Prostaglandin E_2&& | |Common Name=&&11-deoxy Prostaglandin E_2&& | ||
|Source= | |Source= |
Revision as of 13:50, 23 April 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1743 |
LipidMaps | LMFA03010061 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG35 |
11-deoxy Prostaglandin E2 | |
---|---|
Structural Information | |
9-Oxo-15S-hydroxy-prosta-5Z,13E-dien-1-oic acid | |
| |
Formula | C20H32O4 |
Exact Mass | 336.23005951199997 |
Average Mass | 336.46567999999996 |
SMILES | C(CC[C@@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)CCC(=O)1)CC |
Physicochemical Information | |
11-deoxy Prostaglandin E2 shows strong bronchoconstriction of human smooth muscle . Karim_SM et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|